MedPath

CXLUSA

CXLUSA logo
🇺🇸United States
Ownership
Private
Established
2009-01-01
Employees
-
Market Cap
-
Website
http://www.cxlusa.com

Clinical Trials

7

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:2
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Not Applicable
1 (33.3%)

Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas

Phase 2
Terminated
Conditions
Eye Diseases
Keratoconus
Corneal Diseases
Photosensitizing Agents
First Posted Date
2017-01-24
Last Posted Date
2022-01-12
Lead Sponsor
Cxlusa
Target Recruit Count
2228
Registration Number
NCT03029104
Locations
🇺🇸

Schwartz Laser Eye Center, Scottsdale, Arizona, United States

🇺🇸

Goodman Eye Center, San Francisco, California, United States

🇺🇸

Cornea Consultants of Colorado, Littleton, Colorado, United States

and more 6 locations

CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

Phase 2
Terminated
Conditions
Keratoconus
First Posted Date
2013-10-08
Last Posted Date
2018-10-12
Lead Sponsor
Cxlusa
Target Recruit Count
1324
Registration Number
NCT01956474
Locations
🇺🇸

Center for Excellence in Eye Care, Miami, Florida, United States

🇺🇸

Stulting Research Center at Woolfson Eye Institute, Atlanta, Georgia, United States

🇺🇸

TLC Laser Eye Center, Fairfax, Virginia, United States

and more 2 locations

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Not Applicable
Completed
Conditions
Infectious Keratitis
First Posted Date
2012-12-03
Last Posted Date
2018-09-26
Lead Sponsor
Cxlusa
Target Recruit Count
13
Registration Number
NCT01739673
Locations
🇺🇸

Schwartz Laser Eye Center, Scottsdale, Arizona, United States

🇺🇸

Davidorf Eye Group, West Hills, California, United States

🇺🇸

Corneal Consultants of Colorado, PC, Littleton, Colorado, United States

and more 3 locations

Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia

Completed
Conditions
Fruste Keratoconus
Risk of Ectasia
Interventions
Device: Corneal Cross-Linking
First Posted Date
2012-11-14
Last Posted Date
2015-08-24
Lead Sponsor
Cxlusa
Target Recruit Count
22
Registration Number
NCT01726283
Locations
🇺🇸

Schwartz Laser Eye Center, Scottsdale, Arizona, United States

🇺🇸

Clear View Eye & Laser Medical Center, San Diego, California, United States

🇺🇸

The Center for Excellence in Eye Care, Miami, Florida, United States

and more 4 locations

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

Terminated
Conditions
Keratoconus
Ectasia
Degeneration
Interventions
Drug: Ciprofloxicin or Vigamox or other.
Drug: Steroid (FML, Pred Forte, Flarex, etc.)
Drug: Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)
First Posted Date
2010-08-27
Last Posted Date
2018-10-12
Lead Sponsor
Cxlusa
Target Recruit Count
3493
Registration Number
NCT01189864
Locations
🇺🇸

Schwartz Laser Eye Center, Scottsdale, Arizona, United States

🇺🇸

Harvard Eye Associates, Laguna Hills, California, United States

🇺🇸

Clear View Eye & Laser Medical Center, San Diego, California, United States

and more 11 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.